The INSTRIDE 1 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 1 Diabetes.
-
- STATUS
- Recruiting
-
- sponsor
- Mylan GmbH
Summary
The INSTRIDE 1 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 1 Diabetes.
Description
The investigational medication is a potential new type of insulin that is similar to insulin glargine (Lantus®), which you are currently taking. If the investigational medication is approved, it could be a more affordable treatment option, becoming more widely available and benefiting more people with diabetes worldwide. The aim of this study is to see how well the investigational medication works compared with Lantus®. We are looking for about 500 people with Type 1 Diabetes across several countries to take part in the INSTRIDE 1 Study. The maximum length of the study is 66 weeks (just over 1 year). During this time, you will need to visit the study center 22 times (although some visits may be conducted by telephone rather than at the study center) and undergo a number of tests and assessments, including blood tests, checking your vital signs (e.g. heart rate and blood pressure), and physical examinations.
If you decide you would like to take part in the INSTRIDE 1 Study, the study doctor will first do some health checks to make sure that the study is right for you. If you can take part, you will receive either the investigational medication or Lantus® at no charge for the duration of the study. You will also be given an approved short-acting insulin to be used at mealtimes. If you want to find out more about the INSTRIDE 1 Study, please contact the study team using the details below.
Email: info@hansoncrc.com
Tel:941-764-9110
Details
| Condition | Diabetes Mellitus, Type 1 |
|---|---|
| Clinical Study Identifier | TX140043 |
| Sponsor | Mylan GmbH |
| Last Modified on | 23 November 2020 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer